New Hampshire 2023 Regular Session

New Hampshire House Bill HB216

Introduced
1/3/23  
Refer
1/3/23  
Report DNP
2/27/23  

Caption

Exempting dimethyltryptamine from the controlled drug act.

Impact

If enacted, HB 216 would lead to significant changes in the enforcement of drug laws in New Hampshire. Individuals found in possession of DMT would no longer face criminal charges, which proponents argue could alleviate some burdens on the judicial system. Moreover, by removing penalties associated with DMT, the state could potentially allocate resources in a more effective manner to address substance abuse treatment instead of criminal prosecution. However, the exact reduction in charges or judicial proceedings is difficult to quantify, as the bill does not provide a mechanism to track these metrics.

Summary

House Bill 216 aims to exempt dimethyltryptamine (DMT) from New Hampshire's Controlled Drug Act, effectively decriminalizing its possession and use within the state. By removing DMT from the list of regulated substances, the bill seeks to address growing interests in its potential therapeutic benefits, particularly in the contexts of mental health and substance use recovery. This legislative move reflects a broader trend across various jurisdictions that are reconsidering the legal status and potential medical applications of certain psychoactive substances.

Sentiment

The sentiment surrounding HB 216 appears to be cautiously optimistic among supporters, who view the exemption as a positive step towards acknowledging and legitimizing the therapeutic potential of DMT. Advocacy groups focused on drug reform and mental health treatment have expressed support, highlighting the potential for innovation in treatment methods for various psychological conditions. Conversely, there are concerns voiced by some officials and community members regarding the implications of decriminalization, particularly regarding the messaging it sends about substance use and its potential impact on public health.

Contention

Notable points of contention include the balance between public health interests and the risks associated with decriminalizing a substance that, while being researched for its potential benefits, is still largely unregulated and less understood. Critics argue that the absence of oversight could lead to misuse or a lack of appropriate guidance in administering substances like DMT. The debate often revolves around issues of safety, responsible usage, and the adequacy of currently proposed educational programs about the uses and effects of DMT as a substance.

Companion Bills

No companion bills found.

Previously Filed As

NH SB465

classifying xylazine as a schedule III controlled drug.

NH SB15

Relative to establishing a mandatory minimum sentence for the crime of distribution of a controlled drug with death resulting.

NH SB58

Relative to venue in criminal prosecutions of distribution of a controlled drug with death resulting.

NH HB1821

exempting certain information collected from electronic ballot counting devices from right-to-know law restrictions.

NH HB1697

exempting certain firearms and firearm accessories manufactured and retained in New Hampshire from federal regulation.

NH HB473

Criminalizing multiple forms of exposing children to controlled substances and allowing law enforcement to take a child into protective custody for screening and testing in an instance of suspected or actual criminal exposure to controlled substances.

NH HB226

Relative to the use of drug checking equipment.

NH SB467

relative to the penalty for certain fentanyl-related offenses and establishing a mandatory minimum sentence for the crime of distribution of a controlled drug with death resulting.

NH HB2707

Removing a tax exemption for the warehousing and reselling of prescription drugs.

NH SB132

Controlled substances; psychoactive derivatives of hemp added as Schedule I drug

Similar Bills

NH HB114

Removing fees and charges for governmental records under the right-to-know law and reinstating potential liability for disclosure of information exempt from disclosure.

VA HB433

Newborn screening; evaluation of disorders for inclusion, process for considering other disorders.

NH HB95

Requiring the New Hampshire electric co-op regularly file a certificate of deregulation with the public utilities commission.

NH HB507

Relative to the timeline for credentialing of mental health care providers.

NH HB721

Relative to establishing gold and silver as legal tender.

NH HB721

relative to establishing gold and silver as legal tender.

VA HB560

Administrative Process Act; appeals of case decisions regarding benefits sought, limitations.

NH HB185

Relative to reimbursement rates for ambulance service providers.